Where is Organon located?

Organon is headquartered in Jersey City, United States. It is registered at 6, Bredgade, København K, 1260.

How many employees does Organon have?

As of Apr 30, 2026, the latest employee count at Organon is 7379.

Is Organon a funded company?

Organon is a funded company, having raised a total of $***** in its 1st and only funding round.

How much is Organon worth?

The last known valuation of Organon was $***** as of Apr 26, 2026.

What is the annual revenue of Organon?

Annual revenue of Organon is $6.22B as on Dec 31, 2025.

Where does Organon rank among its competitors?

Organon ranks 69th amongst 1284 active competitors, of which 75 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Johnson & Johnson, which secured $34M in Feb, 2025.

Who are the top competitors of Organon?

Organon's top competitors include AbbVie, Amgen and Gilead. Among them, Johnson & Johnson secured the most recent funding round in February, 2025.

Organon - 2026 Company Profile, Team, Competitors & Financials

Q: Is Organon an acquired company?

Organon got acquired by Sun Pharma on Apr 26, 2026.

Organon is an acquired company based in Jersey City (United States), founded in 1923. It operates as a Dutch traditional pharma company acquired by Merck. , with last known valuation of $*****. The company has 1284 active competitors, including 75 funded and 157 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.

Company Details

Organon was a Dutch traditional pharma company acquired by Merck & Co. The company had products in areas of reproductive medicine, contraception, psychiatry, HRT, and anesthesia. It was acquired by Schering-Plough Corporation in 2007. Schering-Plough later merged with Merck & Co in 2009.In 2021, the company recorded annual revenues of $6.47B and a net profit of $1.35B

Website: www.organon.com/
Registered Address: 6, Bredgade, København K, 1260

Key Metrics

Founded Year

1923

Location

Jersey City, United States

Stage

Acquired

Last Known Valuation

$***** as on Apr 26, 2026

Ranked

69^th among 1284 active competitors

Annual Revenue

$6.22B as on Dec 31, 2025

Employee Count

7,379 as on Apr 30, 2026

Investment & Acquisitions

Dermavant & 4 more

Similar Companies

AbbVie & 1310 more

Exit Details

Acquired by Sun Pharma (Apr 26, 2026)

View Organon's full profile

Organon is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Organon Pharma d.o.o. CIN: 24886309951 , Croatia, Active	Apr 20, 2020	$1.75M (As on Dec 31, 2024)	-
ORGANON & CO. CIN: 32084723132 , United States, Active	Jun 23, 2022	-	-	-
Organon Denmark ApS CIN: 41193093 , Denmark, Active	Feb 23, 2020	-	15 (As on Aug 31, 2024)
ORGANON & CO. CIN: 1821825 , United States, Active	Mar 10, 2020	$6.22B (As on Dec 31, 2025)	-	-

Organon got acquired by Sun Pharma on Apr 26, 2026 at an acquisition amount of $*****.

Click here to take a look at Organon's acquisition in detail

Organon is a funded company.

Organon's employee count trend

Organon has 7,379 employees as of Apr 26. Here is Organon's employee count trend over the years:

Uncover Organon's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Organon include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Organon, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Alcor Fund, Berkshire Hathaway & 8 others	81/100
2nd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Amgen Business Development, Gershon Capital ... & 11 others	81/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Temasek & 17 others	80/100
4th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Gershon Capital & 11 others	79/100
5th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Alcor Fund, Western Technology Investment ... & 16 others	76/100
6th	Juno Therapeutics 2013, Seattle (United States), Acquired	Global biopharmaceutical company discovering, developing, and delivering innovative medicines	$317M	BB Biotech, RA Capital Management & 14 others	74/100
7th	Pfizer 1849, New York City (United States), Public	Provider of pharmaceutical products for multiple disease treatments	-	Alcor Fund, Benson Family Private Equity ... & 16 others	72/100
8th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 7 others	72/100
9th	Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public	Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others	-	BB Biotech, Gershon Capital & 7 others	71/100
10th	Novartis 1996, Basel (Switzerland), Public	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, MT Capital & 9 others	70/100
69th	Organon 1923, Jersey City (United States), Acquired	Dutch traditional pharma company acquired by Merck	-	-	51/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Organon's competitors? Click here to see the top ones

Organon has made 1 investments in companies including Claria Medical. Organon has also acquired 4 companies including Dermavant and Forendo Pharma.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Sep 18, 2024	Acquisition	Dermavant	2016	Phoenix (United States)
Jan 05, 2023	Investments	Claria Medical	2017	Mountain View (United States)
Nov 11, 2021	Acquisition	Forendo Pharma	2013	Turku (Finland)